Search
Search Results
##search.searchResults.foundPlural##
-
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
5151PDF: 2995HTML: 2366 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3300PDF: 1698HTML: 403 -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2873PDF: 898HTML: 15035Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 378 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
3438PDF: 675Suppl. Files: 331HTML: 314 -
-
DIAGNOSTIC ACCURACY OF CLINICAL TOOL ‘STOPS’ AND SERUM PROCALCITONIN FOR OPTIMIZING ANTIBIOTIC THERAPY IN NEONATAL SEPSIS STOPS and procalcitonin for optimizing antibiotics in neonatal sepsis
1913PDF: 671HTML: 495 -
THE ROLE OF THE CAROTID DOPPLER EXAMINATION IN THE EVALUATION OF ATHEROSCLEROTIC CHANGES IN BETA THALASSEMIA PATIENTS
2318PDF: 1053HTML: 3074Untitled: 279 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
4129PDF: 1216HTML: 476 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1664PDF: 1098HTML: 149 -
Measurement of erythrocyte lifespan using a CO breath test in patients with thalassemia and the impact of treatment erythrocyte lifespan in patients with thalassemia
910PDF: 632HTML: 218 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4679PDF: 1820HTML: 1339 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
2007PDF: 532HTML: 4052 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1338PDF: 713HTML: 7805 -
-
-
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3576PDF: 1698HTML: 722 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1617PDF: 867Suppl. Files: 369Html: 173 -
-
THE CHALLENGE OF AML IN OLDER PATIENTS
2474PDF: 1065HTML: 2236 -
HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS
2427HTML: 684PDF: 1434 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3978PDF: 1768HTML: 11948Figures Haase: 289 -
Correlation to FVIII:C in two thrombin generation tests: TGA-CAT and INNOVANCE ETP
2355PDF: 855HTML: 911Figure 2: 258Figure 1: 222







